![Mark Heiman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Mark Heiman worked as a Principal at Eli Lilly & Co. and as an Assistant Professor at Tulane University.
He was also the Chief Scientific Officer & Vice President-Research at MicroBiome Therapeutics LLC from 2013 to 2018.
He received his undergraduate degree from the University of New Orleans and his doctorate from LSU Medical School.
Antiguos cargos conocidos de Mark Heiman.
Empresas | Cargo | Fin |
---|---|---|
MicroBiome Therapeutics LLC
![]() MicroBiome Therapeutics LLC Pharmaceuticals: MajorHealth Technology MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA. | Director Técnico/Científico/I+D | 02/01/2018 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Tulane University (Louisiana) | Corporate Officer/Principal | - |
Formación de Mark Heiman.
University of New Orleans | Undergraduate Degree |
Lsu Medical School | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Empresas privadas | 1 |
---|---|
MicroBiome Therapeutics LLC
![]() MicroBiome Therapeutics LLC Pharmaceuticals: MajorHealth Technology MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Heiman